Become A Clinical Trial Volunteer - Touch Another Life
Uh-oh! This study is no longer available.

We're sorry, but the study or condition you’re looking for is no longer available. You can search all currently enrolling studies or contact us if you have any questions.

Early-stage Alzheimer’s Disease Study

Medical Condition

Alzheimers Disease

Facility/Clinic

PMG Research of McFarland Clinic

Age

60 - 85

Gender

Male/Female

Description

A diagnosis of dementia caused by Alzheimer’s disease can be difficult to battle for all involved. This neurological disease accounts for about 80% of all dementia cases. As cognitive abilities and memory loss progress, it hinders normal daily tasks and lowers quality of life. Most with Alzheimer’s disease eventually require 24 hour care from skilled caregivers. Identifying genetic markers and evaluating age-related risks, is one way to catch the disease in its early stages. Starting treatments early can slow the progression, but currently there is no cure. Researchers are developing new treatments that may help those with early stages of Alzheimer’s disease.

Accellacare is currently enrolling volunteers in a study that is evaluating an investigational medication’s ability to address symptoms of early Alzheimer’s disease.

This study may be an option if you or a loved one:

 

  • Is between the ages of 60 – 85 years of age
  • Has a gradual progression of dementia caused by Alzheimer’s disease
  • Has a reliable study partner available to attend study visits
  • Has no other neurological disease other than Alzheimer’s disease 

 

 

 

 

 

 

 

 

Other criteria apply. 

Eligible participants will receive study-related care and study medication at no cost.

Enrollment

Open

Patient Commitment Duration

about 1 year

Patient Compensation

 Financial compensation will also be provided for time and travel expenses.

Number of visits in study

about 14 clinic visits

Apply for this Study Now